Figure 6 | Scientific Reports

Figure 6

From: Protection of layers and breeders against homologous or heterologous HPAIv by vaccines from Korean national antigen bank

Figure 6

Virus shedding in oropharyngeal (OP) and cloacal (CL) swab samples after inoculation with homologous and heterologous HPAIv. Titers of virus shed in OP and CL samples from chickens inoculated with inactivated vaccines, assessed at 3, 5, 7, 10 and 14 days post-infection (dpi) with homologous and heterologous HP H5 viruses. Viral titers are expressed as log10TCID50 (50% tissue culture infectious dose) in 0.1 ml, with error bars included. Vaccines were (A) rgKA435/2.3.2.1c in layer chickens, followed by challenge with homologous and heterologous virus, (B) rgES2/2.3.4.4c in layer chickens, followed by challenge with homologous and heterologous virus, (C) rgKA435/2.3.2.1c in breeder chickens, followed by challenge with homologous and heterologous virus, and (D) rgES2/2.3.4.4c in breeder chickens, followed by challenge with homologous and heterologous virus. The lower limit of detection was 1 log10TCID50 in 0.1 ml.

Back to article page